PubRank

Christine Stadelmann

Author PubWeight™ 91.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat Immunol 2007 5.83
2 Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005 5.29
3 Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 2009 4.88
4 Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain 2009 3.04
5 Remyelination is extensive in a subset of multiple sclerosis patients. Brain 2006 2.43
6 Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathol 2008 1.85
7 Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc Natl Acad Sci U S A 2006 1.79
8 Mechanisms of acute axonal degeneration in the optic nerve in vivo. Proc Natl Acad Sci U S A 2010 1.70
9 Early MRI changes in a mouse model of multiple sclerosis are predictive of severe inflammatory tissue damage. Brain 2007 1.63
10 Thermal hypoaesthesia differentiates secondary restless legs syndrome associated with small fibre neuropathy from primary restless legs syndrome. Brain 2010 1.62
11 Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J Neuropathol Exp Neurol 2003 1.55
12 Effects of interferon-beta-1a on neuronal survival under autoimmune inflammatory conditions. Exp Neurol 2006 1.55
13 Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination. Acta Neuropathol 2012 1.53
14 Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol 2007 1.49
15 Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs. J Clin Invest 2008 1.44
16 Remyelination in multiple sclerosis. J Neurol Sci 2003 1.43
17 Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain Pathol 2007 1.41
18 A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. Brain 2006 1.35
19 Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. Am J Pathol 2004 1.31
20 Enhancing remyelination in disease--can we wrap it up? Brain 2011 1.25
21 Remodeling of axonal connections contributes to recovery in an animal model of multiple sclerosis. J Exp Med 2004 1.25
22 Multicontrast MRI of remyelination in the central nervous system. NMR Biomed 2005 1.19
23 Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases. Ann Neurol 2003 1.15
24 Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis. J Neuroimmunol 2010 1.15
25 Inter-laboratory comparison of neuropathological assessments of beta-amyloid protein: a study of the BrainNet Europe consortium. Acta Neuropathol 2008 1.13
26 Microglia promote colonization of brain tissue by breast cancer cells in a Wnt-dependent way. Glia 2010 1.13
27 Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system. Brain 2008 1.08
28 Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons. Acta Neuropathol 2013 1.08
29 The spectrum of multiple sclerosis: new lessons from pathology. Curr Opin Neurol 2005 1.07
30 Assessment of lesion pathology in a new animal model of MS by multiparametric MRI and DTI. Neuroimage 2011 1.06
31 Lipopolysaccharide injection induces relapses of experimental autoimmune encephalomyelitis in nontransgenic mice via bystander activation of autoreactive CD4+ cells. J Immunol 2005 1.06
32 Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis. Brain 2004 1.04
33 Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas. J Neurooncol 2003 1.04
34 Molecular changes in white matter adjacent to an active demyelinating lesion in early multiple sclerosis. Brain Pathol 2008 1.02
35 Wallerian degeneration: a major component of early axonal pathology in multiple sclerosis. Brain Pathol 2010 1.02
36 Differential upregulation of heme oxygenase-1 (HSP32) in glial cells after oxidative stress and in demyelinating disorders. J Mol Neurosci 2007 1.02
37 Axonal loss and neurofilament phosphorylation changes accompany lesion development and clinical progression in multiple sclerosis. Brain Pathol 2011 0.98
38 Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Brain 2005 0.98
39 From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases. Brain 2008 0.96
40 Ischemia leads to apoptosis--and necrosis-like neuron death in the ischemic rat hippocampus. Brain Pathol 2004 0.96
41 Comparing the pathogenesis of experimental autoimmune encephalomyelitis in CD4-/- and CD8-/- DBA/1 mice defines qualitative roles of different T cell subsets. J Neuroimmunol 2003 0.94
42 Selective vulnerability of different types of commissural neurons for amyloid beta-protein-induced neurodegeneration in APP23 mice correlates with dendritic tree morphology. Brain 2006 0.94
43 Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions. Acta Neuropathol 2013 0.94
44 An N-terminally truncated envelope protein encoded by a human endogenous retrovirus W locus on chromosome Xq22.3. Retrovirology 2010 0.93
45 Carcinoma cells misuse the host tissue damage response to invade the brain. Glia 2013 0.92
46 Neuroaxonal regeneration is more pronounced in early multiple sclerosis than in traumatic brain injury lesions. Brain Pathol 2012 0.90
47 Differential macrophage/microglia activation in neocortical EAE lesions in the marmoset monkey. Brain Pathol 2006 0.90
48 Bacterial pore-forming cytolysins induce neuronal damage in a rat model of neonatal meningitis. J Infect Dis 2010 0.89
49 Expression of stathmin, a developmentally controlled cytoskeleton-regulating molecule, in demyelinating disorders. J Neurosci 2005 0.89
50 Increased expression of BDNF and proliferation of dentate granule cells after bacterial meningitis. J Neuropathol Exp Neurol 2005 0.88
51 Problems of cell death in neurodegeneration and Alzheimer's Disease. J Alzheimers Dis 2001 0.88
52 Dopamine D3 receptor specifically modulates motor and sensory symptoms in iron-deficient mice. J Neurosci 2011 0.88
53 Human glioma-initiating cells show a distinct immature phenotype resembling but not identical to NG2 glia. J Neuropathol Exp Neurol 2013 0.87
54 Suppression of autoimmune encephalomyelitis by a neurokinin-1 receptor antagonist--a putative role for substance P in CNS inflammation. J Neuroimmunol 2006 0.86
55 Severe spinal muscular atrophy variant associated with congenital bone fractures. J Child Neurol 2002 0.86
56 18F-FDG PET detects inflammatory infiltrates in spinal cord experimental autoimmune encephalomyelitis lesions. J Nucl Med 2012 0.86
57 Tolerance induction by bone marrow transplantation in a multiple sclerosis model. Blood 2005 0.85
58 Fas (CD95/Apo-1)/Fas ligand expression in neonates with pontosubicular neuron necrosis. Pediatr Res 2002 0.85
59 Differential regulation of myelin phagocytosis by macrophages/microglia, involvement of target myelin, Fc receptors and activation by intravenous immunoglobulins. J Neurosci Res 2002 0.84
60 PI3Kγ deficiency delays the onset of experimental autoimmune encephalomyelitis and ameliorates its clinical outcome. Eur J Immunol 2011 0.83
61 Substantial early, but nonprogressive neuronal loss in multiple sclerosis (MS) spinal cord. Ann Neurol 2009 0.83
62 Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelination. Acta Neuropathol 2014 0.81
63 Multifocal osteochondroma after repeated irradiation in a boy with Hodgkin disease. J Pediatr Hematol Oncol 2005 0.81
64 Behavioral testing strategies in a localized animal model of multiple sclerosis. J Neuroimmunol 2004 0.81
65 Hyperoxia causes inducible nitric oxide synthase-mediated cellular damage to the immature rat brain. Pediatr Res 2003 0.80
66 Calcium influx and calpain activation mediate preclinical retinal neurodegeneration in autoimmune optic neuritis. J Neuropathol Exp Neurol 2013 0.80
67 Simvastatin treatment does not protect retinal ganglion cells from degeneration in a rat model of autoimmune optic neuritis. Exp Neurol 2005 0.78
68 Gray matter pathology and multiple sclerosis. Curr Neurol Neurosci Rep 2009 0.78
69 Brain derived neurotrophic factor does not act on adult human cerebral endothelial cells. Neurosci Lett 2002 0.77
70 Membrane-type 1 metalloproteinase is upregulated in microglia/brain macrophages in neurodegenerative and neuroinflammatory diseases. J Neurosci Res 2013 0.77
71 Clinicopathological considerations in acute disseminated encephalomyelitis (ADEM): a fulminant case with favorable outcome. J Neurol 2011 0.77
72 Exogenous schwann cells migrate, remyelinate and promote clinical recovery in experimental auto-immune encephalomyelitis. PLoS One 2012 0.76
73 Increased Meningeal T and Plasma Cell Infiltration is Associated with Early Subpial Cortical Demyelination in Common Marmosets with Experimental Autoimmune Encephalomyelitis. Brain Pathol 2014 0.76
74 Atypical appearance of a primary central nervous system lymphoma. Arch Neurol 2006 0.75
75 Remyelination After Cuprizone-Induced Demyelination Is Accelerated in Juvenile Mice. J Neuropathol Exp Neurol 2015 0.75